GlobeNewswire
-
Exicure Announces Strategic Expansion into Parkinson’s Disease
20/11/2026 -
MMI élargit les capacités énergétiques du système chirurgical Symani® avec le lancement des ciseaux monopolaires NanoWrist®
20/11/2026 -
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
20/11/2026 -
Belite Bio Announces Extension of FDA Review Timeline for Tinlarebant NDA
20/11/2026 -
HYTN Innovations Inc. and Peptide Development Labs Inc. Announce Trading of PEPT Common Shares on the Canadian Securities Exchange
20/11/2026 -
iMDx Expands GraftAssure Utilization as First Patient Samples Arrive for GALACTIC Registry Study
20/11/2026 -
Annovis Secures FDA Agreement on Integrated Summary of Safety Plan, Combining Alzheimer’s and Parkinson’s Data Ahead of Buntanetap NDA
20/11/2026 -
Allogene Therapeutics to Host Events at American Society of Hematology Annual Meeting 2026 Highlighting the Potential of Allogeneic CAR T to Expand Patient Access
20/11/2026 -
Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness
20/11/2026 -
JAMA Study Using Alamar Biosciences’ NULISA Assay Links Blood eMTBR-tau to Tau tangle Burden in Former Football Players with Advanced CTE
20/11/2026 -
Polaryx Therapeutics Highlights Participation in NCL Scientific Conference and NTSAD Imagine & Believe Event
20/11/2026 -
Biotricity Reports Second Quarter Fiscal 2027 Results
20/11/2026 -
MMI Adds Energy Capabilities to the Symani® Surgical System with the Introduction of NanoWrist® Monopolar Scissors
20/11/2026 -
Aprea Therapeutics Announces Interim Results From the Ongoing First-in-human Phase 1 Study of WEE1 Inhibitor APR-1051 in Patients with Advanced Solid Tumors (ACESOT-1051) at the 38th EORTC-NCI-AACR Symposium in Barcelona
20/11/2026 -
Walmart Canada amasse plus de 3,9 millions de dollars au profit des programmes de secours et de préparation aux urgences de la Croix-Rouge canadienne
20/11/2026 -
Canadian Red Cross and Walmart Canada’s annual campaign raises more than $3.9 million for disaster relief and preparedness
20/11/2026 -
Hair Loss Treatment: A Normal Blood Count Does Not Rule Out Iron Deficiency Hair Loss, and Most Treatment Never Orders the Ferritin Test
20/11/2026 -
Protext Mobility, Inc. (OTC: TXTM) Chairman’s Strategic Shareholder Update
20/11/2026 -
NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering
20/11/2026
Pages